May 10, 2004
Sponsored by the Children's AIDS Fund
Mary K. Pendergast, JD, LLM, is President of Pendergast Consulting in Washington, DC, providing strategic and tactical advice to biotech and pharmaceutical corporations, governments, professional and patient groups, and institutions on regulatory issues relating to compliance and drug development. Ms. Pendergast served as Deputy Commissioner and Senior Advisor to the Commissioner at the Food and Drug Administration (FDA) from 1990 through 1998. From 1979 through 1990 she served as Associate Chief Counsel for Enforcement at the FDA.
Jeremiah Norris is an Adjunct Fellow at the Hudson Institute's Washington DC office, working primarily on issues in the global HIV/AIDS environment. He served as Senior Director for Operations and International Affairs with the WebMD Foundation, charged with developing a joint UN-private sector partnership to bridge the digital divide in public health through deployment of a Health InterNetwork for developing nations. He served as a Senior Advisor for the Harvard Medical School's international programs, worked with Project Hope, with USAID and with the Peace Corps.
Justina A. Molzon, MS Pharm, JD, is Associate Director for International Programs at the Center for Drug Evaluation and Research at the Food and Drug Administration.
Richard Wagner is the Founder, Chairman and Chief Executive of US based AMFA Foundation, Inc., and is also the Founder, Chairman and Chief Executive of Affordable Medicines for Africa (AMFA), a South African Section 21 not-for-gain organization. Mr. Wagner is based in Johannesburg, South Africa. He spent nearly 30 years holding various positions in for-profit businesses in the Chicago area. In 1991, Mr. Wagner joined the staff of MAP International, a US charitable organization distributing donated pharmaceutical products to the developing world. He served MAP as Executive Vice President and Chief Operating Officer and was a member of the Board of Directors.
Edmund C. Tramont, MD, FACP, is director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases in the National Institutes of Health. Formerly Associate Director of the Walter Reed Army Institute of Research, Dr. Tramont has served as a consultant to the Office of the Surgeon General and to the Food and Drug Administration. He is a Professor and Associate Director of the Institute of Human Virology at the University of Maryland Biotechnology Institute in Baltimore.
Deborah L. Birx, MD, is the director of the US Military HIV Research Program, a multi-dimensional research project encompassing vaccine development and prevention of HIV, to clinical studies of novel HIV treatments. Dr. Birx serves on numerous councils and boards including the NIH Office of AIDS Research Advisory Council, the Executive Steering Committee of the Partnership in AIDS Vaccine Evaluation, the International Advisory Working Group of the NAID HIV Vaccine Trial Network, and the UNAIDS Vaccine Advisory Committee. Dr. Birx is a Colonel and medical officer in the United States Army.
Joseph F. O'Neill, MD, MS, MPH, was named a Deputy Coordinator and Chief Medical Officer in the Office of the US Global AIDS Coordinator at the Department of State in August 2003. The Office of the US Global AIDS Coordinator oversees all US international HIV/AIDS assistance and coordinates the efforts of the various agencies and departments that delivery it. Prior to joining the State Department, Dr. O'Neill served as the Director of the White House Office of National AIDS Policy, where he served as the lead advisor to the President on domestic and international HIV/AIDS issues. Prior to his White House appointment, Dr. O'Neill served as Acting Director of HIV/AIDS Policy in the Department of Health & Human Services and as former Associate Administrator for HIV/AIDS in the Health Resources and Services Administration's HIV/AIDS Bureau and former Director of the national Ryan White Comprehensive AIDS Resources Emergency (CARE) Act.
Robert R. Redfield, Jr., MD, is a Professor of Medicine and Professor of Immunology and Microbiology at the University of Maryland in Baltimore, the Associate Director and Co-founder of the Institute of Human Virology, the University of Maryland Biotechnology Institute, Director of Clinical Care and Research at the Institute of Human Virology, and Director of the Clinical HIV Program at the University of Maryland School of Medicine. Dr. Redfield served as Project Director of HIV Immunotherapy at the Walter Reed Army Institute of Research and as Project Director HIV Vaccine Development for Treatment and Prevention for the Military Medical Consortium for Applied Retroviral Research, Department of Defense.